A study comparing commonly used medications for type 2 diabetes has found that sulfonylurea drugs are associated with a reduced risk of out-of-hospital cardiac arrest compared with metformin. The research is published today in the British Journal of Clinical Pharmacology and presented at EHRA 2021, an online scientific congress of the European Society of Cardiology (ESC).
